ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1253

Acupuncture in Rheumatoid Arthritis Activity

Diana Seixas1, Fátima Farinha2, Marcos Pacheco da Fonte3, Manuel Laranjeira1 and Marília Rua4, 1ICBAS, Porto, Portugal, 2CHUP-HSA, Porto, Portugal, 3CHEDV, Santa Maria da Feira, Portugal, 4University Aveiro, Aveiro, Portugal

Meeting: ACR Convergence 2021

Keywords: Disease Activity, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 8, 2021

Title: RA – Treatments Poster II: PROs, Biomarkers, & Systemic Inflammation (1223–1256)

Session Type: Poster Session C

Session Time: 8:30AM-10:30AM

Background/Purpose: High activity rates of Rheumatoid Arthritis (RA) lead to an increased risk of mortality. RA patients have a high incidence of comorbidities, associated with the chronic inflammatory process, with joint inflammation and deformity, loss of functional capacity and quality of life. Although over time it is difficult to sustain low disease activity / remission rates, associated with a decrease in functional disability and therefore a better quality of life, reaching these goals in a timely manner leads to better functional and quality of life outcomes for patients (1). The objective of the study was to investigate the effect of acupuncture, combined with the pharmacological treatment instituted, on RA activity, through DAS28-CRP.

1 Scott IC, Ibrahim F, Panayi G, Cope AP, Garrood T, Vincent A, et al. The frequency of remission and low disease activity in patients with rheumatoid arthritis, and their ability to identify people with low disability and normal quality of life. Seminars in Arthritis and Rheumatism 49 (2019) 20-26

Methods: Randomized, prospective and controlled experimental study. Patients were submitted one acupuncture session per week for 8 consecutive weeks, with DAS28-CRP evaluation immediately before the 1st acupuncture session and another evaluation one week after the last acupuncture session. The 101 patients were randomly assigned to an Experimental Group (EG), submitted to acupuncture (n=50) and Control Group (CG), not submitted to acupuncture (n=51). All maintained pharmacological treatment in progress, not initiating any another pharmacological and / or non-pharmacological treatment during the present study.

Results: The results obtained in the first evaluation were similar between the study groups, with no significant differences that allow them to be distinguished from each other, mean (4,129 versus 4,245) and median (4,220 versus 4,200), classifying them as EG and CG, respectively, with moderate activity, defined by DAS28-CRP. In the evaluation carried out after treatment with acupuncture for EG patients, it was obtained through the DAS28-CRP score, mean (2,993) and median (4,541). CG patients, in the last evaluation, presented different and very significant results, namely the mean (4,541) and median (4,705). According to the definition by DAS28-CRP, after treatment with acupuncture, the EG decreased the disease activity index, defining itself with low activity, in contrast to the CG that maintained values very close to those of the first evaluation, with a moderate disease activity index. This statistical evidence is graphically explained in Graph 1 and Graph 2.

Conclusion: The effect of acupuncture was evident in patients whose treatment was combined with the pharmacological treatment already in place. The decrease in the DAS28-CRP score was clearly visible, and it’s possible to inform that acupuncture, when combined with treatment already underway, allows to decrease RA activity. Thus, acupuncture may be a non-pharmacological intervention to start early, when diagnosing RA, as a way of managing and treating the disease, based on the individual needs of each patient.

Graph 1 – Boxplot DAS28-CRP scores: 1st Review Experimental Group and Control Group

Graph 2 – Boxplot DAS28-CRP scores: 2nd Review Experimental Group and Control Group


Disclosures: D. Seixas, None; F. Farinha, None; M. Pacheco da Fonte, None; M. Laranjeira, None; M. Rua, None.

To cite this abstract in AMA style:

Seixas D, Farinha F, Pacheco da Fonte M, Laranjeira M, Rua M. Acupuncture in Rheumatoid Arthritis Activity [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/acupuncture-in-rheumatoid-arthritis-activity/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/acupuncture-in-rheumatoid-arthritis-activity/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology